Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Director/PDMR Shareholding

14 Apr 2020 07:30

RNS Number : 5304J
Circassia Pharmaceuticals Plc
14 April 2020
Β 

Director/PDMR Shareholding

Oxford, UK - 14 April 2020:Β Circassia Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR), a specialty biopharmaceutical company focused on respiratory disease, today announces that on 9 April 2020, Ian Johnson, Executive Chairman of Circassia purchased 200,000 Ordinary Shares at a price of 22.85 pence per share, Michael Roller, Chief Financial Officer purchased 200,000 Ordinary Shares at a price of 22.683 pence per share and Jonathan Emms, Chief Operating Officer of Circassia, purchased 300,000 Ordinary Shares at a price of 23.2 pence per share.

Following these purchases, Ian Johnson holds 200,000 Ordinary Shares (0.05% of the issued share capital of the Company), Michael Roller holds 200,000 Ordinary Shares (0.05% of the issued share capital of the Company) and Jonathan Emms holds 600,000 Ordinary Shares (0.16% of the issued share capital of the Company).

Contacts

Circassia Pharmaceuticals plc

Ian Johnson Executive Chairman

Michael Roller Chief Financial Officer

c/o FTI Consulting

Β 

Β 

Peel Hunt LLP (Nominated Adviser and Broker)

James Steel / Oliver Jackson

Β 

Tel: +44 (0)20 7418 8900

finnCap (Joint Broker)

Geoff Nash / Alice Lane

Β 

Tel: +44 (0) 20 7220 0500

Numis Securities (Joint Broker)

James Black / Duncan Monteith

Β 

Tel: +44 (0) 20 7260 1000

FTI Consulting

Simon Conway / Ciara Martin

Tel: +44 (0) 20 3727 1000

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Ian Johnson

2. Michael Roller

3. Jonathan Emms

2.

Reason for the notification

a.

Position/status

1. Executive Chairman

2. Chief Financial Officer

3. Chief Operating Officer

b.

Initial notification

/Amendment

Β 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Circassia Pharmaceuticals plc

b.

LEI

2138006YAT138TOGA556

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary Shares of 0.08p each

Β 

Β 

GB00BJVD3B28

b.

Nature of the transaction

Purchase of Ordinary Shares

Β 

c.

Price(s) and volume(s)

Β 

Price(s)

Β 

Volume(s)

1. 22.85p

2. 22.683p

3. 23.2p

1. 200,000

2. 200,000

3. 300,000

d.

Aggregated information

Β· Aggregated volume

Β· Price

Β 

Β 

Β 

n/a

Β 

e.

Date of the transaction

2020-04-09

f.

Place of the transaction

London Stock Exchange, AIM

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHGLGDSCDBDGGS
Date   Source Headline
1st Sep 20225:45 pmRNSChange of Company Name
1st Sep 202211:00 amRNSResult of General Meeting and Change of Name
11th Aug 20227:00 amRNSProposed Change of Name and Notice of GM
29th Jul 202210:41 amRNSTotal Voting Rights
21st Jul 20223:30 pmRNSChange of Auditor
14th Jul 20227:00 amRNSTrading Update
5th Jul 20223:57 pmRNSHolding(s) in Company
30th Jun 202211:54 amRNSTotal Voting Rights
29th Jun 202211:00 amRNSUpdate regarding Beyond Air product approval
10th Jun 20221:06 pmRNSHolding(s) in Company
31st May 202211:08 amRNSTotal Voting Rights
27th May 20229:53 amRNSExtension of Block Admission
25th May 20224:41 pmRNSSecond Price Monitoring Extn
25th May 20224:35 pmRNSPrice Monitoring Extension
20th May 20227:00 amRNSGrant of Options
12th May 202212:04 pmRNSResult of AGM
12th May 20227:00 amRNSAGM Statement
3rd May 20224:01 pmRNSChange of Registered Office
29th Apr 202210:32 amRNSTotal Voting Rights
13th Apr 20226:17 pmRNSAnnual Report and Notice of AGM
1st Apr 20227:00 amRNSBlock listing Interim Review
1st Apr 20227:00 amRNSTotal Voting Rights
29th Mar 20222:18 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSBlock Admission
22nd Mar 20227:00 amRNSPreliminary Results
31st Jan 202210:24 amRNSTotal Voting Rights
28th Jan 20222:15 pmRNSHolding(s) in Company
13th Jan 20227:00 amRNSTrading Statement
4th Jan 202210:40 amRNSTotal Voting Rights
30th Nov 20217:00 amRNSTotal Voting Rights
29th Nov 20218:54 amRNSBlock Listing Application
5th Oct 20213:06 pmRNSExtension of Block Admission
30th Sep 20213:15 pmRNSBlock listing Interim Review
21st Sep 20215:18 pmRNSHolding(s) in Company
17th Sep 20217:00 amRNSDirector/PDMR Shareholding
16th Sep 20217:00 amRNSInterim Results - Ended 30 June 2021
1st Sep 20212:52 pmRNSTotal Voting Rights
30th Jul 20217:00 amRNSTotal Voting Rights
13th Jul 20217:00 amRNSFirst Half Trading Update
30th Jun 202111:15 amRNSTotal Voting Rights
26th May 20217:00 amRNSSettlement Agreement reached with Beyond Air
21st May 202110:58 amRNSResult of AGM
21st May 20217:00 amRNSAGM Statement
5th May 20216:30 pmRNSHolding(s) in Company
30th Apr 202112:32 pmRNSTotal Voting Rights
21st Apr 20217:00 amRNSAnnual Report and Notice of AGM
6th Apr 202112:56 pmRNSDirector/PDMR Shareholding
1st Apr 20219:00 amRNSBlock Listing Application
31st Mar 202112:14 pmRNSBlock listing Interim Review
24th Mar 20217:01 amRNSSubscription to raise £5 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.